636 POSTER Initial safety findings from a phase III study of capecitabine (X) plus oxaliplatin (XELOX) vs. infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) in first-line treatment of patients (pts) with metastatic colorectal cancer (MCRC)

• Book ID: 118623213
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 258 KB
• Volume: 3
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(05)80932-2